RFP
RCEL icon

Root Financial Partners’s Avita Medical RCEL Stock Holding History

Root Financial Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107 Buy
+29
New +$122 ﹤0.01% 3268

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Root Financial Partners's RCEL Position: Q1 2026 in Review

Root Financial Partners opened a new position in Avita Medical (RCEL) in Q1 2026: 29 shares worth $107. The stake represents ﹤0.01% of the portfolio and ranks #3268 among its holdings.

79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Root Financial Partners held 29 shares of Avita Medical worth $107 as of Q1 2026.
  • Avita Medical was a new Root Financial Partners position in Q1 2026.
  • Avita Medical made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3268 holding.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.